Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2026 ,inter alia, to consider and approve Board Meeting Intimation for consideration of Unaudited Financial Results for the Half Year ended on September 30, 2026 and Closure of Trading Window

APTUS PHARMA LIMITED Date: 15/10/2026 Corporate Rela(cid:415)on Departments The BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400001 SECURITY CODE: 544529 SCRIPT SYMBOL: APPL ISIN: INE15XJ01010 Subject: In(cid:415)ma(cid:415)on of Board Mee(cid:415)ng for considera(cid:415)on of Unaudited Financial Results for the Half Year ended on September 30, 2026 and Closure of Trading Window. Dear Sir/Madam, Pursuant to Regula(cid:415)on 29(1)(a) read with Regula(cid:415)on 33 of the SEBI (Lis(cid:415)ng Obliga(cid:415)ons and Disclosure Requirements) Regula(cid:415)ons, 2015, we hereby inform you that a mee(cid:415)ng of the Board of Directors of the Company is scheduled to be held on Tuesday, 20th October 2026, inter alia, to consider and approve the Unaudited Financial Results of the Company for the half year ended 30th September 2026 and to take on record the Limited Review Report thereon. Further, in accordance with the Company's Code of Conduct for Prohibi(cid:415)on of Insider Trading pursuant to SEBI (Prohibi(cid:415)on of Insider Trading) Regula(cid:415)ons, 2015 and as per our in(cid:415)ma(cid:415)on dated 28/09/2026, the Trading Window for dealing in the Company’s securi(cid:415)es has been closed from October 1, 2026 and shall remain closed un(cid:415)l comple(cid:415)on of 48 hours a(cid:332)er the declara(cid:415)on of the said financial results You are requested to kindly take the above informa(cid:415)on on record and disseminate the same on your website. Thanking you, Yours faithfully, For Aptus Pharma Limited Tejash Maheshchandra Hathi Managing Director DIN: 03151221 Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logis(cid:415)c Park, Aslali, Daskroi, Ahmedabad, Gujarat – 382427, India Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM